Merit Medical to Participate at Six Conferences

BTIG – March 1
Raymond James – March 7
Barclays – March 15
Oppenheimer – March 21
Needham – March 28
Sidoti – March 29

SOUTH JORDAN, Utah, Feb. 22, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that it will participate at six investor conferences in March.

On Thursday, March 1, Merit’s Chief Financial Officer Bernard Birkett will participate in one-on-one meetings at BTIG’s Healthcare Conference in Snowbird, Utah.

On Wednesday, March 7, at 7:30 a.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos will present at Raymond James & Associates’ 39th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida. He will also participate in one-on-one meetings throughout the day.

On Thursday, March 15, at 10:45 a.m. ET, Lampropoulos will present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel. He will also participate in one-on-one meetings throughout the day.

On Wednesday, March 21, Lampropoulos will participate in one-on-one meetings at Oppenheimer’s 28th Annual Healthcare Conference at the Westin Grand Central Hotel in New York City.

On Wednesday, March 28, at 4:30 p.m. ET, Birkett will present at the Needham Healthcare Conference at the Westin Grand Central Hotel in New York City. He will also participate in one-on-one meetings throughout the day.

On Thursday, March 29, at 9:45 a.m. ET, Birkett will present at Sidoti and Company’s 2018 Spring Conference at their offices in New York City. He will also participate in one-on-one meetings throughout the day.

ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Yishun, Singapore.

Contact:  Anne-Marie Wright, Vice President, Corporate Communications
Phone:   (801) 208-4167  e-mail: awright@merit.com  Fax: (801) 253-1688

Ads

You May Also Like

國際肺癌研究協會發布第18屆世界肺癌大會的精選論文摘要

丹佛, Sept. 09, 2017 (GLOBE NEWSWIRE) -- 國際肺癌研究協會(IASLC)今天發布第18屆世界肺癌大會(WCLC)的精選論文摘要。研討會將於2017年10月15至18日在日本橫濱舉行,由全球各地的世界級研究人員、醫生、護理師和宣導者簡報其研究,焦點是肺癌預防及治療和橫跨多個不同範疇的科學的最新發展,包括手術、放射治療、標靶治療、免疫治療、病患衛教宣傳等。 醫學博士、哲學博士、科羅拉多大學癌症中心(University of Colorado Cancer Center)和醫學院的醫學及病理學教授兼IASLC執行長Fred R. ...

TESARO Announces U.S. FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy

VARUBI injectable emulsion features a ready-to-use, single-dose vial for intravenous administrationAvailability of new formulation ...